A recent study published in The Lancet refutes the claim that Tylenol use during pregnancy is linked to an increased risk of autism. The study, conducted by scientists from Italy, Sweden, Norway, and the UK, is a comprehensive review of global research on the relationship between acetaminophen (the active ingredient in Tylenol) and childhood neurodevelopmental disorders. This is the second major research journal to publish a study addressing the controversial claims made by U.S. President Donald Trump in September, which were widely criticized as 'dangerous pseudoscience' by autism advocacy groups. Trump's statements, alongside U.S. health officials like Robert F. Kennedy Jr., urged pregnant women to avoid acetaminophen, despite its long-standing safety record in treating pain and fever during pregnancy. The earlier study, published by the British Medical Journal, also found insufficient evidence to support a link between acetaminophen use and autism or ADHD. However, the Lancet's review is considered more robust due to its meta-analysis and adjustment for genetic risk factors. Researchers found no evidence that acetaminophen use in pregnancy increases the risk of autism, ADHD, or intellectual disability. Autism expert Stephen Scherer, who has conducted groundbreaking research on the genetics of autism, echoed this finding, emphasizing that the study's conclusions align with existing scientific knowledge. Despite this, concerns persist among healthcare professionals that pregnant women may avoid acetaminophen due to Trump's unproven claims, potentially impacting both mother and baby. Tali Bogler, chair of family medicine obstetrics at St. Michael's Hospital in Toronto, has observed a rise in anxiety and hesitancy regarding acetaminophen use during pregnancy. However, Eda Karacabeyli, a clinical assistant professor at the University of British Columbia, notes that patients have not entirely spurned the medication. The study's publication highlights the ongoing challenges in addressing public misconceptions about vaccine safety and neurodevelopmental disorders, drawing parallels to the 1998 Andrew Wakefield paper, which falsely linked the MMR vaccine to autism. Researchers in Canada are now engaged in 'difficult conversations' about how to address the fears perpetuated by the Trump administration, emphasizing the need for evidence-based information and collaboration with autistic individuals and their families.
